Ashton Thomas Securities LLC decreased its position in abrdn Healthcare Investors (NYSE:HQH – Free Report) by 41.6% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,809 shares of the financial services provider’s stock after selling 9,838 shares during the period. Ashton Thomas Securities LLC’s holdings in abrdn Healthcare Investors were worth $214,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also bought and sold shares of HQH. Costello Asset Management INC purchased a new position in abrdn Healthcare Investors in the first quarter worth about $40,000. US Bancorp DE raised its holdings in abrdn Healthcare Investors by 192.8% in the 1st quarter. US Bancorp DE now owns 3,733 shares of the financial services provider’s stock worth $61,000 after acquiring an additional 2,458 shares during the last quarter. Integrated Wealth Concepts LLC purchased a new position in abrdn Healthcare Investors in the 1st quarter worth approximately $166,000. Wealth Enhancement Advisory Services LLC bought a new position in abrdn Healthcare Investors in the 1st quarter valued at approximately $189,000. Finally, Goldman Sachs Group Inc. boosted its stake in abrdn Healthcare Investors by 7.2% during the 1st quarter. Goldman Sachs Group Inc. now owns 11,732 shares of the financial services provider’s stock valued at $191,000 after purchasing an additional 788 shares during the last quarter. 32.60% of the stock is currently owned by institutional investors.
abrdn Healthcare Investors Price Performance
abrdn Healthcare Investors stock opened at $18.61 on Friday. abrdn Healthcare Investors has a 12 month low of $13.77 and a 12 month high of $18.86. The stock has a fifty day simple moving average of $16.63 and a two-hundred day simple moving average of $15.98.
abrdn Healthcare Investors Cuts Dividend
About abrdn Healthcare Investors
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.
See Also
- Five stocks we like better than abrdn Healthcare Investors
- Trading Stocks: RSI and Why it’s Useful
- After Trump Deal, Can Meta Stock Withstand TikTok’s Onslaught?
- What is the Australian Securities Exchange (ASX)
- Alphabet: After Its Best Quarter in Decades, Is It Time to Buy?
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Forget Airlines—These Trucking Stocks Are Shifting Into High Gear
Want to see what other hedge funds are holding HQH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for abrdn Healthcare Investors (NYSE:HQH – Free Report).
Receive News & Ratings for abrdn Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for abrdn Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.